Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin treatment in pediatric long chain fatty acid oxidation disorders
TCTR20210604002Not yet recruiting
- Sponsor
- N/A
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of triheptanoin in long-chain fatty acid oxidation disorder (LC-FAOD), sponsored by N/A. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
triheptanoin
03
Conditions
long-chain fatty acid oxidation disorder (LC-FAOD)
Beyond the preview
Go deeper on TCTR20210604002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210604002.